Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Atherectomy Devices Market, by Type
1.4.2 Europe Atherectomy Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Atherectomy Devices Market by Type
3.1 Europe Directional Atherectomy Market by Country
3.2 Europe Rotational Atherectomy Market by Country
3.3 Europe Orbital Atherectomy Market by Country
3.4 Europe Laser Atherectomy Market by Country
Chapter 4. Europe Atherectomy Devices Market by Country
4.1 Germany Atherectomy Devices Market
4.1.1 Germany Atherectomy Devices Market by Type
4.2 UK Atherectomy Devices Market
4.2.1 UK Atherectomy Devices Market by Type
4.3 France Atherectomy Devices Market
4.3.1 France Atherectomy Devices Market by Type
4.4 Russia Atherectomy Devices Market
4.4.1 Russia Atherectomy Devices Market by Type
4.5 Spain Atherectomy Devices Market
4.5.1 Spain Atherectomy Devices Market by Type
4.6 Italy Atherectomy Devices Market
4.6.1 Italy Atherectomy Devices Market by Type
4.7 Rest of Europe Atherectomy Devices Market
4.7.1 Rest of Europe Atherectomy Devices Market by Type
Chapter 5. Company Profiles
5.1 Cardiovascular Systems, Inc.
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Regional Analysis
5.1.4 Research & Development Expense
5.1.5 Recent strategies and developments:
5.1.5.1 Collaborations, partnerships and agreements:
5.1.5.2 Acquisition and mergers:
5.2 Avinger, Inc.
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Regional Analysis
5.2.4 Research & Development Expense
5.2.1 Recent strategies and developments:
5.2.1.1 Product launches:
5.2.1.2 Approval:
5.3 Straub Medical AG
5.3.1 Company Overview
5.4 Boston Scientific Corporation
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental and Regional Analysis
5.4.4 Research & Development Expense
5.4.5 Recent strategies and developments:
5.4.5.1 Acquisition and mergers:
5.5 Medtronic PLC (Covidien)
5.5.1 Company overview
5.5.2 Financial Analysis
5.5.3 Segmental and Regional Analysis
5.5.4 Research & Development Expenses
5.5.5 Recent strategies and developments:
5.5.5.1 Acquisition and mergers:
5.5.5.2 Approval:
5.6 Koninklijke Philips N.V.
5.6.1 Company Overview
5.6.2 Financial Analysis
5.6.3 Segmental and Regional Analysis
5.6.4 Research & Development Expenses
5.6.5 Recent strategies and developments:
5.6.5.1 Acquisition and mergers:
5.7 Cardinal Health, Inc. (Cordis)
5.7.1 Company Overview
5.7.2 Financial Analysis
5.7.3 Segmental and Regional Analysis
5.8 Terumo Corporation (Terumo IS)
5.8.1 Company Overview
5.8.2 Financial Analysis
5.8.3 Segmental Analysis
5.8.4 Recent strategies and developments:
5.8.4.1 Acquisition and mergers:
5.8.4.2 Expansions:
5.9 Abbott Laboratories
5.9.1 Company Overview
5.9.2 Financial Analysis
5.9.3 Segmental and Regional Analysis
5.9.4 Research & Development Expense
5.9.5 Recent strategies and developments:
5.9.5.1 Acquisition and mergers:
5.1 B. Braun Melsungen AG
5.10.1 Company Overview
5.10.2 Financial Analysis
5.10.3 Segmental and Regional Analysis
5.10.4 Research & Development Expense
Unique Offerings 